MultiPlan (MultiPlan) ROCE % : -29.57% (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is MultiPlan ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. MultiPlan's annualized ROCE % for the quarter that ended in Mar. 2024 was -29.57%.

MultiPlan ROCE % Historical Data

The historical data trend for MultiPlan's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MultiPlan ROCE % Chart

MultiPlan Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

4.68

-2.57

4.96

-3.37

3.23

MultiPlan Quarterly Data
	Dec18	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial														4.79	2.07	3.07	2.99	-29.57

MultiPlan ROCE % Calculation

MultiPlan's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	226.148	/	( ( (7371.104 - 175.844)	+	(6964.687 - 166.739) )	/ 2 )
	=	226.148	/	( (7195.26	+	6797.948)	/ 2 )
	=	226.148	/	6996.604
	=	3.23 %

MultiPlan's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	-1917.868	/	( ( (6964.687 - 166.739)	+	(6366.695 - 194.112) )	/ 2 )
	=	-1917.868	/	( ( 6797.948	+	6172.583 )	/ 2 )
	=	-1917.868	/	6485.2655
	=	-29.57 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

MultiPlan (NYSE:MPLN) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

MultiPlan ROCE % Related Terms

Thank you for viewing the detailed overview of MultiPlan's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

MultiPlan (MultiPlan) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » MultiPlan Corp (NYSE:MPLN) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

115 Fifth Avenue, New York, NY, USA, 10003

Website

https://www.multiplan.us

MultiPlan Corp is a provider of data analytics and technology-enabled solutions designed to bring affordability, efficiency, and fairness to the U.S. healthcare industry. The company interprets clients' needs and customizes solutions that combine its payment integrity, network-based, and analytics-based services. The Company's focus is being a value-added provider of data analytics and technology-enabled end-to-end cost management, payment and revenue integrity solutions to the U.S. healthcare industry.

Executives

John Michael Prince	director	115 FIFTH AVE., NEW YORK NY 10003
Nutter Carol	officer: SVP, Chief People Officer	115 FIFTH AVE., NEW YORK NY 10003
Anthony Jr Colaluca	director	MULTIPLAN CORPORATION, 115 FIFTH AVENUE, NEW YORK NY 10003
Mark Tabak	director, officer: Chief Executive Officer	115 FIFTH AVENUE, NEW YORK NY 10003
Michael Kim	officer: See Remarks	POLARIS PARENT CORP, 115 FIFTH AVENUE, NEW YORK NY 10003
Michael K. Attal	director	425 PARK AVENUE, 30TH FLOOR, NEW YORK NY 10022
James M Head	officer: EVP & Chief Financial Officer	3001 COLORADO BLVD, DENTON TX 76210
Julie D Klapstein	director	1239 FRUIT COVE ROAD NORTH, JACKSONVILLE FL 32259
C Martin Harris	director
H&f Corporate Investors Viii, Ltd.	10 percent owner	415 MISSION STREET, SUITE 5700, SAN FRANCISCO CA 94105
Music Investments Gp, Llc	10 percent owner	C/O HELLMAN & FRIEDMAN, ONE MARTIME PLAZA, 12TH FLOOR, SAN FRANCISCO CA 94111
Music Investments, L.p.	10 percent owner	C/O HELLMAN & FRIEDMAN, ONE MARTIME PLAZA, 12TH FLOOR, SAN FRANCISCO CA 94111
Glenn R August	director	C/O OHA - 1114 AVENUE OF THE AMERICAS, 27TH FLOOR, NEW YORK NY 10036
Paul Galant	officer: President, New Markets	88 WEST PLUMERIA DRIVE, SAN JOSE CA 95134
Michael Stuart Klein	director, 10 percent owner, officer: Chief Executive Officer	C/O DAVIS POLK & WARDWELL, 450 LEXINGTON AVENUE, NEW YORK NY 10017